Clinical Trials

Company-Supported Clinical Trials

Key clinical trials sponsored by Mallinckrodt for branded drugs are listed on www.clinicaltrials.gov and detailed below, with a link provided to learn more and an indicator of the current phase of development.

Study TitlePHASE
1
PHASE
2
PHASE
3
PHASE
4
A Multicenter, 2-Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis
More Information >
      X
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin (CONFIRM)
More Information >
    X  
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With  Active Systemic Lupus Erythematosus (SLE)
More Information >
      X
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
More Information >
  X    
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy (BRAVE) More Information >   X    
ACTH as a Re-emerging Therapy for Uveitis (The ACTHAR Study) More Information >       X
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease    
More Information >
      X
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
More Information >
X      
Follow up Study of Patients Having Participated in Clinical Trial 64,185-204 (JASMINE_205)
More Information >
       
Observational Registry Of H.P. Acthar® Gel for Multiple Sclerosis Relapse
More Information >
      X
Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Pulmonary Sarcoidosis
More Information >
      X
Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Relapsing-Remitting Multiple Sclerosis (OPTIONS)
More Information >
      X
Registry Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide (PaTTerN)
More Information >
      X
Safety and Efficacy Study of Raplixa™ (Fibrin Sealant [Human]) to Treat Surgical Bleeding in Children
More Information >
  X    
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
More Information >
    X  
StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
More Information >
  X    
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS (PODOCYTE)
More Information >
      X
UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease
More Information >
    X